competition success magazine published this article page no 23 india has gained recognition for its supply of affordable generic drugs worldwide. however the expenditure on research and development in the pharma sector remains relatively low. currently the r&d sector only accounts for 7% of the overall expenditure in the indian pharma industry while developed countries allocate over 35% to r&d activities. recognizing this gap the government aims to encourage pharma giants to prioritize investment in r&d facilitating breakthroughs in both communicable and non-communicable diseases competition success magazine subscription.
No comments:
Post a Comment